CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-10 | Sylvain Jereme M EVP Chief Financial Officer | Returned to the company | −783 | $111.40 | $87K | 77,111 |
| 2023-03-10 | Stern Sadie EVP Chief Human Resources Offi | Returned to the company | −2,550 | $111.40 | $284K | 87,603 |
| 2023-03-10 | Stern Sadie EVP Chief Human Resources Offi | Returned to the company | −3,565 | $111.40 | $397K | 84,038 |
| 2023-03-10 | Selvaraj Shelly Ramasamy SVP Chief Information Officer | Returned to the company | −2,089 | $111.40 | $233K | 58,895 |
| 2023-03-10 | Selvaraj Shelly Ramasamy SVP Chief Information Officer | Returned to the company | −1,737 | $111.40 | $194K | 57,158 |
| 2023-03-10 | Selvaraj Shelly Ramasamy SVP Chief Information Officer | Returned to the company | −2,646 | $111.40 | $295K | 54,512 |
| 2023-03-10 | SAYER KEVIN R President CEO and Chairman of | Returned to the company | −17,302 | $111.40 | $1.9M | 368,457 |
| 2023-03-10 | SAYER KEVIN R President CEO and Chairman of | Returned to the company | −9,141 | $111.40 | $1.0M | 359,316 |
| 2023-03-10 | SAYER KEVIN R President CEO and Chairman of | Returned to the company | −11,047 | $111.40 | $1.2M | 348,269 |
| 2023-03-10 | Regan Barry J. EVP Operations | Returned to the company | −2,406 | $111.40 | $268K | 75,756 |
| 2023-03-10 | Regan Barry J. EVP Operations | Returned to the company | −3,274 | $111.40 | $365K | 72,482 |
| 2023-03-10 | Pacelli Steven Robert EVP Managing Director Dexcom V | Returned to the company | −3,274 | $111.40 | $365K | 151,966 |
| 2023-03-10 | Pacelli Steven Robert EVP Managing Director Dexcom V | Returned to the company | −5,990 | $111.40 | $667K | 145,976 |
| 2023-03-10 | Pacelli Steven Robert EVP Managing Director Dexcom V | Returned to the company | −2,405 | $111.40 | $268K | 143,571 |
| 2023-03-10 | Leach Jacob Steven EVP Chief Technology Officer | Returned to the company | −3,540 | $111.40 | $394K | 302,946 |
| 2023-03-10 | Leach Jacob Steven EVP Chief Technology Officer | Returned to the company | −7,986 | $111.40 | $890K | 294,960 |
| 2023-03-10 | Leach Jacob Steven EVP Chief Technology Officer | Returned to the company | −4,583 | $111.40 | $511K | 290,377 |
| 2023-03-10 | Flynn Paul R EVP Global Revenue | Returned to the company | −5,478 | $111.40 | $610K | 69,042 |
| 2023-03-10 | Flynn Paul R EVP Global Revenue | Returned to the company | −5,724 | $111.40 | $638K | 63,318 |
| 2023-03-10 | Flynn Paul R EVP Global Revenue | Returned to the company | −5,643 | $111.40 | $629K | 57,675 |
Page 18 of 40 · 785 trades